Literature DB >> 24894794

Re: steroid-resistant nephrotic syndrome: impact of genetic testing.

Muhammed Mubarak1, Aiysha Abid.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24894794      PMCID: PMC6074863          DOI: 10.5144/0256-4947.2014.191

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


× No keyword cloud information.
  5 in total

Review 1.  Genetics of steroid-resistant nephrotic syndrome: a review of mutation spectrum and suggested approach for genetic testing.

Authors:  S Joshi; R Andersen; B Jespersen; S Rittig
Journal:  Acta Paediatr       Date:  2013-07-10       Impact factor: 2.299

2.  Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.

Authors:  Sheila Santín; Gemma Bullich; Bárbara Tazón-Vega; Rafael García-Maset; Isabel Giménez; Irene Silva; Patricia Ruíz; José Ballarín; Roser Torra; Elisabet Ars
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 8.237

3.  A spectrum of novel NPHS1 and NPHS2 gene mutations in pediatric nephrotic syndrome patients from Pakistan.

Authors:  Aiysha Abid; Shagufta Khaliq; Saba Shahid; Ali Lanewala; Mohammad Mubarak; Seema Hashmi; Javed Kazi; Tahir Masood; Farkhanda Hafeez; Syed Ali Anwar Naqvi; Syed Adeebul Hasan Rizvi; Syed Qasim Mehdi
Journal:  Gene       Date:  2012-04-28       Impact factor: 3.688

4.  The spectrum of histopathological lesions in children presenting with steroid-resistant nephrotic syndrome at a single center in Pakistan.

Authors:  Muhammed Mubarak; Javed I Kazi; Shaheera Shakeel; Ali Lanewala; Seema Hashmi
Journal:  ScientificWorldJournal       Date:  2012-05-02

5.  Steroid-resistant nephrotic syndrome: impact of genetic testing.

Authors:  Jameela A Kari; Sherif M El-Desoky; Mamdooh Gari; Khalid Malik; Virginia Vega-Warner; Svjetlana Lovric; Detlef Bockenhauer
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.